Back to Results
First PageMeta Content
Center for Biologics Evaluation and Research / Food and Drug Administration / Influenza / Pneumococcal polysaccharide vaccine / National Institute of Allergy and Infectious Diseases / Vaccine injury / Health / Safety / Vaccines / Medicine / Drug safety


March 04, 2014 ADVISORY COMMISSION ON CHILDHOOD VACCINES (ACCV) Parklawn Building, 5600 Fishers Lane, Rockville, Maryland Conference Room[removed]March 06 & 07, [removed]:00pm – 4:15 pm Eastern Daylight Time)
Add to Reading List

Document Date: 2014-03-04 17:40:24

Open Document

File Size: 74,09 KB

Share Result on Facebook

City

Rockville / /

Company

Pneumococcal Polysaccharide (Pneumovax 23) Vaccine Safety Review / /

Facility

Parklawn Building / National Institute of Allergy / /

Organization

Division of Vaccine Injury Compensation / National Institute of Health / National Institute of Allergy and Infectious Diseases / MPH CDC / Food and Drug Administration / Department of Justice / ADVISORY COMMISSION ON CHILDHOOD VACCINES / Center for Biologics / Immunization Safety Office / National Vaccine Program Office / Centers for Disease Control and Prevention / /

Person

Torts Branch / Skip Wolfe / David King / Elaine / Barbara Mulach / Miller / Steve / Tom Shimabukuro / /

/

Position

Chair / King / Chair / Acting Director / R.N. / Deputy Director / /

SocialTag